SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹155 Cr | ₹128 Cr | ₹34 Cr | ₹12 Cr |
What is the latest Total Non-Current Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹12 Cr |
How is Total Non-Current Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 21.55 | |
| Mar2024 | ₹128 Cr | 279.35 | |
| Mar2023 | ₹34 Cr | 175.40 | |
| Mar2022 | ₹12 Cr | - | |
Compare Total Non-Current Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,477.7 Cr | -5% | 6.8% | 126.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -5% |
6.8% |
126.4% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses